Wolfpack Research this morning released a short report on Inspire Medical Systems. "The annual market opportunity promoted by its management is so preposterous that it...
Oppenheimer analyst Jason Helfstein upgraded Snap to Outperform from Perform with an $18 price target. The company is "executing on all metrics," Helfstein tells investors...
BofA analyst John Murphy downgraded Tesla to Underperform from Neutral with a price target of $485, down from $500. The shares closed Tuesday down 8%,...
Facebook announced a $5.7B investment in Jio Platforms Limited, part of Reliance Industries, making Facebook its largest minority shareholder. Facebook said, "This investment underscores our...
Stifel analyst Scott Devitt downgraded Netflix to Hold from Buy with a price target of $460, up from $440. The company last night reported meaningfully...
Shares of Snap (SNAP) are up sharply afterhours, rising about 20% following Q1 results, with in-line earnings, above-consensus revenue, and better than expected user engagement....
Stocks fell again today as the meltdown in oil that created negative prices yesterday in a soon-to-expire contract spread past the expiring contract and weighed...
Mizuho analyst Mara Goldstein initiated coverage of Iovance Biotherapeutics with a Buy rating and $61 price target. The stock closed Tuesday down 3c to $36.63....